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Ask a Different Question, Get a Different Answer:
Why Living Wills are Poor Guides
to Care Preferences at the End of Life
Laraine Winter, Ph.D.,1 Susan M. Parks, M.D.,2 and James J. Diamond, Ph.D.2

Abstract

Context: Living wills have a poor record of directing care at the end of life, as a copious literature attests. Some
speculation centers on the questionable correspondence between the scenario described in living wills versus the
real-life circumstances that typically arise at the end of life.
Objective: To assess the strength of association between responses to a standard living will question and
preferences for treatments in six end-of-life scenarios.
Design: Cross-sectional.
Setting: Telephone interviews.
Participants: Two hundred two community-dwelling men and women 70 years of age or older in the greater
Philadelphia area.
Main outcome measures: Strength of preferences for four life-sustaining treatments in each of six poor-health
scenarios.
Results: Associations between responses to the standard living will question and preferences for treatment
(means across the four) in six specific scenarios were statistically significant but modest in size, accounting for
23% of variance at most. The association for the worse-case scenario (severe stroke with coma) was significantly
stronger than for any other association.
Conclusions: The modest correspondence between living will responses and wishes for life-sustaining treatment
in specific scenarios helps to elucidate the living will’s poor performance. Presentation of more realistic end-oflife scenarios should improve the living will’s ability to guide care, as well as preparing patients and families
better for the end of life.

Introduction

A

dvance care planning has been advocated since the
passage of the 1990 Patient Self-Determination Act
(PSDA) as a means of improving decision making at the end
of life. The goal of such planning is to ensure that patients’
preferences guide future medical care in the event of their
incapacity.1–3 Advance care planning includes written advance directives such as living wills, which specify the medical treatments patients would or would not want, and=or
durable powers of attorney for health care.
Unfortunately, advance care planning in the United States
is still suboptimal despite the PSDA.4 Even when living wills
have been prepared (no more than 21% of patients complete
them), they may not be available in the setting where death
occurs,5 and even when available, care preferences recorded

in living wills are often discarded when patients approach the
end of life.1,2,6–8 Some investigators have concluded that
living wills are ineffective and should be abandoned.9–10
Why have these documents performed so poorly? One
issue is that preferences may change over time or with a decline in patient’s health status.11 Sicker patients, compared to
healthier, tend to regard aggressive treatment as more acceptable.12 Another possible explanation is that the scenario
described in the living will does not correspond well to clinical
circumstances that typically arise at the end of life.4,6 For example, in Pennsylvania and elsewhere, the living will declaration is worded as follows: ‘‘Would you direct your
physician to withhold or withdraw life-sustaining treatment
that serves only to prolong the process of dying, if you should
be in a terminal condition or in a state of permanent unconsciousness?’’13 The life-sustaining treatment is described as
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futile and is associated with prolonged dying. The alternative
to this treatment is not named. In effect, this living will
question poses the choice, ‘‘If you knew you were dying,
would you want futile treatment?’’
Underlying this declaration is the assumption that patients
will know when they are dying. This is a fundamental problem
for two reasons. First, as the NIH Consensus Conference on
Improving End of Life Care14 concluded, the interval known
as end of life is seldom identified as such while the patient is
still alive. Evidence does not support a definition of the interval referred to as the end of life until after the patient’s death.
Another problem concerns prognostication. Christakis and
associates15 have described and documented multiple problems surrounding prognostication, including the absence of
physician training and the reluctance of physicians to provide
prognoses.16 As a consequence, few patients are informed that
their condition is terminal or given prognoses. Thus, the circumstances that emerge when the patient is dying will probably not resemble the scenario described in the living will
because the patient (1) may not have received a prognosis and
(2) will not recognize that he=she is in a terminal condition.
To what extent do responses to such living will questions
correspond to wishes for care in specific and more realistic
end-of-life scenarios? The present study explored a possible
explanation for the disappointing performance of the living
will by examining associations between responses to questions asked during the same interview, eliminating the possibility that changes in preference over time might explain any
weak association. Thus, the present study contributes to the
advance care directives literature by pinpointing a single
issue: the possible mismatch between end-of-life scenario
described in the living will and specific and common end-oflife circumstances. A related question concerns whether some
scenarios may correspond better to the living will question
than others. If so, living wills might be better guides to
treatment preferences in some circumstances than in others.
Method
Subjects
Two hundred two elderly men and women (70 years of age
or older) were recruited through a variety of sources selected
to provide a representative sample of elders. Letters of invitation were mailed to patients 70 or older at two family medicine practices, members of two senior centers, residents of two
retirement communities in suburban Philadelphia, and residents of two Philadelphia senior housing facilities. In addition,
display ads were placed in two Philadelphia newspapers.
Participants’ mean age was 77.4 years (standard deviation
[SD] ¼ 5.6), and 72.3% were female. Whites constituted 65.5%
of the sample, and most non-whites were African American.
Individuals of Protestant affiliation constituted 49.0%, Jews
25.7%, Catholics 16.3%, 3.0% ‘‘other,’’ and 5.9% stated ‘‘none’’
in response to religious affiliation. The majority (71.8%) had
attended college, graduated, or received postgraduate education. All were cognitively intact as measured by the MiniMental State Examination (MMSE) telephone version.17
Measures
Standard living will question. Each participant was
asked, ‘‘Would you direct your physician to withhold or

WINTER ET AL.
withdraw life-sustaining treatment that serves only to prolong the process of dying, if you should be in a terminal
condition or in a state of permanent unconsciousness?’’ Possible responses were ‘‘yes’’ (would not want life-sustaining
treatment), ‘‘no’’ (would want life-sustaining treatment), or
‘‘I don’t know.’’
Life-sustaining treatment preferences. Treatment
preferences were operationalized using questions about 4 lifesustaining treatments (antibiotics, gallbladder surgery, cardiopulmonary resuscitation [CPR], tube feeing) in each of 6
poor-health scenarios, for a total of 24 questions. This followed the approach used in the Life Support Preferences
Questionnaire (LSPQ18,19). The scenarios varied in cognitive
impairment, physical impairment, and presence or absence of
pain (Alzheimer’s disease, severe shortness of breath, severe
stroke with coma, moderate stroke, cancer with no pain, and
cancer with pain; see Appendix A). Thus, for each scenario
(e.g., Alzheimer’s disease) participants were asked how much
they would want antibiotics (‘‘If you developed a serious infection, like pneumonia, would you want to use antibiotics to
treat the infection?’’), CPR (‘‘If your heart stopped beating or
you stopped breathing, would you want to receive CPR?’’),
gallbladder surgery (‘‘If your gallbladder became inflamed
and infected, would you want to have surgery to remove it?’’),
and tube feeding (‘‘If your condition becomes such that you
lose the ability to take in food or water by mouth, would you
want to have artificial feeding and fluids?’’). For each treatment in each scenario, participants responded on 0–4 scales
(0 ¼ definitely would not want, 1 ¼ probably would not want,
2 ¼ unsure, 3 ¼ probably would want, 4 ¼ definitely would
want). Appendix A presents the treatments and scenarios.
Cognitive status. Cognitive status was assessed using a
telephone version of the MMSE,17 which excludes items that
must be administered face to face. Possible scores range from
0 to 23, with 23 indicating no errors. All participants scored 17
or higher, with a mean of 21.4 (SD ¼ 1.6).
Other variables. The questionnaire also included demographic characteristics (age, race, gender, years of education, occupation, financial difficulty, and marital status),
health status (activities of daily living operationalized by seven basic activities of daily living [ADL20]) and seven instrumental activities (IADL21), a religiosity measure,22 and an
end-of-life values scale.23 These variables were not pertinent
to the present study.
Procedure
Interested elders contacted the research office at Jefferson
by calling or mailing in a postage-paid return envelope provided in the mailings. Prior to the interview, the study was
explained further, eligibility and willingness to participate
were established, and an Institutional Review Boardapproved verbal Informed Consent was obtained for each
participant. The interview was conducted on the telephone at
that time or on a subsequent date. It took approximately
35 minutes. Because the topic of the study was end-of-life
decision making, it was natural to ask the living will question
(‘‘Would you direct your physician to withhold or withdraw life-sustaining treatment . . . ?’’) early in the interview.
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Table 1. Mean (SD) Preferences for Life-Sustaining Care and Associations (Point Biserial Coefficients)
with Advance Directive Responses, by Scenario

Scenario
Shortness of breath
Moderately severe stroke=arm and leg paralyzed
Colon cancer that has spread to the liver, no pain
Alzheimer’s disease
Colon cancer that has spread to the liver, with pain
Severe stroke, in coma
a

Those not wanting
Those wanting
Point biserial
life-sustaining care
correlation
All (n ¼ 202) life-sustaining care
meana (SD) (n ¼ 177) meana (SD) (n ¼ 25) meana (SD) coefficientb
2.44
1.64
1.49
1.44
0.94
0.55

(1.46)
(1.60)
(1.59)
(1.56)
(1.44)
(1.16)

2.28
1.47
1.29
1.25
0.75
0.34

(1.49)
(1.54)
(1.51)
(1.49)
(1.30)
(0.92)

3.49
2.88
2.78
2.84
2.34
2.04

(0.64)
(1.53)
(1.56)
(1.37)
(1.68)
(1.55)

0.272
0.396
0.307
0.337
0.366
0.484

0–4 scale: 0 ¼ definitely do not want=1 ¼ probably do not want=2 ¼ unsure=3 ¼ probably want=4 ¼ definitely want.
All were statistically significant at p < 0.0001.

b

The Life-sustaining Treatment Preferences were asked toward
the end. Thus, we presented elderly individuals with both
types of questions - the living will question and a set of
questions about four type of treatments (e.g., tube feeding) in
6 specific scenarios. The administration of the two types of
questions during the same interview minimizes the possibility
that changes with time could explain any weak associations
between responses to the two types of questions.
Data analysis
Mean preferences across all 4 treatments were computed
for each scenario (e.g., Alzheimer’s disease), yielding 6 scores
ranging from 0 to 4.0. For the living will question, ‘‘I don’t
know’’ responses were combined with the ‘‘no’’ responses
(would want life-sustaining care), following the reasoning that
the provision of life-sustaining care is the default option in the
U.S. health care system. Therefore, patients who do not say
‘‘Yes’’ to the withhold=withdraw option are likely to receive
life-sustaining care.24 Thus, living will responses were treated
as a dichotomous variable.
We first examined differences in treatment preferences by
scenarios using analysis of variance (ANOVA) with post-hoc
pair-wise comparisons. In addition, we computed mean
preferences for those elders who agreed that they would direct their physician to withhold life-sustaining treatment
versus those that said they would not or were unsure. Pointbiserial correlation coefficients were used to assess strength of
association between the dichotomous living will responses
and the preferences for life-sustaining care. Low associations
between these responses would support the proposition that
living wills perform poorly because they fail to describe realistic circumstances.
To examine whether some scenarios correspond better than
others to the living will question, the significance of the difference between pairs of associations with living will responses was calculated using Pearson product-moment
correlations and applying Cohen’s formula for significance of
the differences between dependent r’s.25
Results
In response to the living will question, 87.6% said yes, indicating that they would direct their physician to withhold or
withdraw life-sustaining care; 8.9 % said no (i.e., they would
want life-sustaining care), and 3.5% said they did not know.

Preferences for life-sustaining treatments
per scenario
Table 1 presents mean preferences for life-sustaining care in
the scenarios, representing the mean across the four treatments.
The six poor-health scenario differed significantly from each
other in strength of preferences for life-sustaining treatment
(F[6,196] ¼ 152.74.27, p < 0.0001). Post-hoc pair-wise comparisons showed that all pairs of scenarios differed significantly
except Alzheimer’s disease, cancer with no pain, and moderate
stroke ( p’s  0.096). This indicates that participants distinguish
among scenarios in their wishes for life-sustaining treatments.
Strength of association between living
will responses and treatment preferences
Point biserial correlation coefficients between living will
responses and mean treatment preferences in the six scenarios
ranged from 0.27 to 0.48 (Table 1). Thus, at most these two
measures share 23% of variance. The strongest correlation
was for the ‘‘severe stroke with coma’’ scenario, arguably the
most similar to the living will question. For the other scenarios, the living will response accounted for only 7%–15% of
variance. This association for the severe stroke scenario was
significantly stronger than associations between living will
responses and treatment preferences in all other scenarios
(t’s  3.0, p’s < 0.05). Other scenarios did not differ from each
other (t’s  1.32, p’s > 0.05).
Discussion
Responses to a standard living will question were significantly associated with preferences in each scenario but associations were modest. At best, the living will responses
accounted for 23% of variance (for the severe stroke with
coma scenario). For other scenarios associations were significantly weaker. Thus, most variance in scenario-based preferences was not explained by responses to the standard living
will question. This may help elucidate the disappointing
performance of living wills in predicting patients’ treatment
preferences at the end of life. The standard living will question
describes an extreme and clear-cut hypothetical scenario, one
that is relatively easy to respond to but unlikely to approximate the circumstances that most patients face at the end of
life. As noted earlier, the absence of prognosis and the fact that
the end of life will probably not be recognized as such insure
that the patient will not recognize that he=she is terminally ill.
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Thus, end-of-life circumstances are unlikely to resemble the
standard living will scenario. It is telling that standard living
will responses best predicted treatment preferences for severe
stroke with coma, an association that was significantly
stronger than all others.
This study contributes to the current understanding of
advance care planning by underscoring a specific problem:
the mismatch between the scenario described in a standard
living will and scenarios that more accurately approximate
circumstances that emerge at the end of life. By administering
both types of questions in the same interview, study findings
distinguish this mismatch from other possible explanations
for the poor performance of the living will, such as the time
lapse between living will completion and the actual end of life.
Limitations and directions for future research
The present research was limited by reliance on a sample of
volunteers, who may not be representative of the elderly
population. The study should be replicated with a probability
sample or at least a larger and more geographically diverse
sample. The present study also did not examine preferences
for individual treatments described in many living wills. It
would be interesting to know how well living will preferences
for specific treatments (e.g., feeding tube) correspond to the
preferences for those treatments in specific end-of-life scenarios. Finally, whether participants fully understand descriptions of health states and treatments is always a concern
in advance directives research (as it is in practice). Several
considerations should provide confidence in the data, however. The fact that the LSPQ questions are administered oneon-one by a trained interviewer allows participants to express
confusion and misunderstandings and to seek clarification. In
addition, numerous studies based on the LSPQ report little
missing data or inconsistencies in responses. It should also
be noted that the LSPQ is considerably more detailed and
informative than the standard living will, and more time is
allocated for it than is generally provided for administering a
living will.26,27
Implications: The acceptability of death,
the unacceptability of dying
Although the present findings may be taken as further
argument against the living will, a better approach might be
to discard questions that describe circumstances like ‘‘a terminal condition or state of permanent unconscious’’ and
treatments that ‘‘serve only to prolong the process of dying’’
and to substitute a description of circumstances that approximate those more likely to occur. In addition, descriptions of
life-sustaining treatments (e.g., CPR) should provide probability estimates of their effectiveness in sustaining life. Patients
should not be presented with a choice between treatments
labeled as likely to prolong the dying process vs. an implicit,
unnamed, abstract death. Their dying experience will not be
an abstraction, and their actual choice will involve treatments
such as CPR that may not described as futile even if their
likelihood of success is in fact low.28,29
Given the choice posed in the living will, it is hardly surprising that most people choose death. But a dying patient,
offered a treatment presumed to be effective (or why would
the doctor offer it?) vs. the palpable experience of dying, may
understandably opt for the treatment. Our study findings
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suggest that death as an abstraction (as left unnamed and
undescribed in a standard living will) is acceptable, dying (in
a specific scenario) less acceptable. Patient decisions may
seem to change when in fact they are responses to very different questions, because the living will is irrelevant to the
real-life experience of dying or the treatments offered.
A strong argument can certainly be made that advance
care planning should be an ongoing process, revisited at
regular intervals, because of the complexity of the issues,30
the natural tendency of patients to vacillate,31 and the fact
that goals of care may change.11 Yet, even with regularly
updated planning discussions, standard living wills will
nevertheless fall short in guiding care, because the end of life
as it unfolds will not correspond to the improbable scenario
described in the living will. Advance care planning may be
helpful to patients and families by improving the likelihood
patients will receive palliative care earlier and undergo less
futile care.32–34 But effective advance care documents must
inform patients and families frankly and fully about the
circumstances and treatment choices that they are likely to
face at the end of life.
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Appendix A.
Four Life-Sustaining Treatments

Antibiotics: Doctors use these medicines to treat serious infections (like pneumonia). Without antibiotics, serious infections can
cause life-threatening complications or death.
Cardiopulmonary resuscitation (CPR): Doctors use cardiopulmonary resuscitation, or CPR, when a person’s heart stops
beating or a person stops breathing. Doctors press on the chest to help pump blood, and use artificial breathing. Artificial
breathing means the doctor puts a tube in the windpipe. Then, a machine breathes for the patient through the tube. Patients
usually get medicine by vein. Patients often need an electrical shock to help restart the heartbeat. Without CPR, the heart will
not start beating again, and the patient will die.
Gallbladder surgery: Doctors use surgery to remove the gall bladder when it is inflamed and infected. If untreated, an inflamed
and infected gall bladder can rupture and cause life-threatening complications or death.
Artificial Feeding and Fluids: Doctors use artificial feeding and fluids when people are unable to take enough food and water
to stay alive. The food goes through a feeding tube. Usually, the feeding tube is inserted into the stomach through the left side of
the abdomen during surgery. The stomach is stitched closed around the tube. Without the treatment, patients die within 7–10
days.
Six Poor-Health Scenarios
Alzheimer’s disease: You have trouble remembering things and thinking clearly. You cannot recognize people you know,
make decisions for yourself, or communicate. You have no chance of recovery. Your mental abilities may get worse quickly or
may stay the way they are now for a long time. Your physical condition and abilities are unaffected.
Constant shortness of breath as result of a condition such as congestive heart failure, emphysema, or COPD: You are unable
to climb stairs or walk more than a few feet. Your medical condition cannot improve. Your condition may get worse very
quickly or slowly decline over several years. Your ability to think, reason, and remember is unaffected.
Severe stroke: You have suffered a severe stroke and have been in a coma for six weeks. In the opinion of the doctor, you have
no chance for regaining awareness. Your current physical condition is stable but will slowly decline over time. You rely on others
for help with feeding, bathing, dressing, and toileting. You may live in this condition for several years.
Moderately severe stroke: One arm and leg are paralyzed. You have trouble speaking and trouble understanding when others
speak. You rely on others for help with feeding, dressing, bathing and toileting. In the opinion of your doctor, you have a very
slight chance of improvement.
Colon cancer that has spread to the liver, no pain: You are tired and weak. Your thinking and memory are unaffected. You are
not in pain. In the opinion of your doctor, you have no chance of recovery. Your doctor estimates that you have about six months
to live.
Colon cancer that has spread to the liver, with pain: You are tired and weak. Your thinking and memory are unaffected. You
have pain that requires the constant use of medication. In the opinion of your doctor, you have no chance of recovery. Your doctor
estimates that you have about six months to live.
Sample Question
You have Alzheimer’s disease. You have trouble remembering things and thinking clearly. You cannot recognize people you
know, make decisions for yourself, or communicate. You have no chance of recovery. Your mental abilities may get worse
quickly or may stay the way they are now for a long time. Your physical condition and abilities are unaffected.
If you developed a serious infection, like pneumonia, would you want to use antibiotics to treat the infection?

Definitely
do not want
0()

Probably
do not want

Unsure

Probably
want

Definitely
want

NA

Refused

1()

2()

3()

4()

-2 ( )

-4 ( )

This article has been cited by:
1. J. Andrew Billings. 2012. The Need for Safeguards in Advance Care Planning. Journal of General Internal Medicine .
[CrossRef]
2. Ruth D. Piers, Ineke J. van Eechoud, Sigrid Van Camp, Mieke Grypdonck, Myriam Deveugele, Natacha C. Verbeke, Nele J.
Van Den Noortgate. 2011. Advance Care Planning in terminally ill and frail older persons. Patient Education and Counseling
. [CrossRef]
3. Danielle N. Ko, Pedro Perez-Cruz, Craig D. Blinderman. 2011. Ethical Issues in Palliative Care. Primary Care: Clinics in
Office Practice 38:2, 183-193. [CrossRef]
4. Jessica Krok, Debra Dobbs, Kathryn Hyer, LuMarie Polivka-West. 2011. Nurse manager's perspectives of structural and
process characteristics related to resident's advance directives in nursing homes. Applied Nursing Research . [CrossRef]
5. Esther Mok, Fion H Ting, Ka-po Lau. 2010. Advance directives and life-sustaining treatment: informed attitudes of Hong
Kong Chinese elders with chronic disease. Journal of Nursing and Healthcare of Chronic Illness 2:4, 313-319. [CrossRef]
6. 2010. Bibliography. Progress in Palliative Care 18:5, 297-326. [CrossRef]

